Gain of function/dominant negative mutations in SETBP1, a gene encoding the oncogene-binding protein, SET-binding protein 1, has been reported to be the causative genetic defect in SGS [7]. This evidence concerns the gene SETBP1 and Schinzel-Giedion syndrome.